May 28, 2026 08:00AM
May 12, 2026 05:00PM
May 6, 2026 07:00AM
May 6, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 1, 2026 05:05PM Eupraxia Pharmaceuticals names Dr. Jeymi Tambiah as chief medical officer
May 1, 2026 05:05PM
Apr 22, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 13, 2026 08:00AM
Mar 17, 2026 07:00AM
Mar 17, 2026 07:00AM Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
Mar 12, 2026 09:03PM
Jan 8, 2026 07:34AM
Jan 8, 2026 07:34AM
Nov 13, 2025 05:00PM
Nov 13, 2025 05:00PM
Nov 4, 2025 04:39PM
Sep 29, 2025 05:00PM Eupraxia reports positive results from highest dose in EoE trial
Sep 29, 2025 05:00PM
Sep 2, 2025 08:02AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 04:25PM
Jul 22, 2025 05:17PM
Jul 8, 2025 07:00AM Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
Jul 8, 2025 07:00AM
Jun 2, 2025 06:30PM
May 7, 2025 02:00PM
May 6, 2025 06:00PM
May 5, 2025 07:00AM
Apr 24, 2025 05:00PM
Mar 20, 2025 05:32PM Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Feb 25, 2025 07:01AM
Feb 25, 2025 07:00AM
Feb 18, 2025 07:00AM
Feb 18, 2025 07:00AM
Nov 20, 2024 07:00AM
Nov 14, 2024 05:00PM
Nov 13, 2024 05:00PM Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2
Nov 12, 2024 05:56PM
Oct 31, 2024 07:36PM
Oct 28, 2024 07:00AM
Oct 15, 2024 07:00AM
Oct 15, 2024 07:00AM
Oct 10, 2024 07:00AM
Oct 2, 2024 05:01PM Eupraxia Pharmaceuticals (EPRX) Strengthens Senior Management Team
Oct 2, 2024 05:01PM

322,093 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All